Gene expression signatures prognostic for relapse in stage I testicular germ cell tumours-Reference-Cited by-同舟云学术

Gene expression signatures prognostic for relapse in stage I testicular germ cell tumours

Published:2018-05-31 Issue:5 Volume:122 Page:814-822
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Lewin Jeremy¹^ORCID,Soltan Ghoraie Laleh²,Bedard Philippe L.¹,Hamilton Robert J.³,Chung Peter⁴,Moore Malcolm⁵,Jewett Michael A.S.³,Anson-Cartwright Lynn⁴,Virtanen Carl⁶,Winegarden Neil⁷,Tsao Julie⁷,Warde Padraig⁴,Sweet Joan⁸,Haibe-Kains Benjamin²,Hansen Aaron R.¹

Affiliation:

1. Division of Medical Oncology and Hematology; Princess Margaret Cancer Centre; Toronto ON Canada

2. Bioinformatics and Computational Genomics Laboratory; Princess Margaret Cancer Centre; Toronto ON Canada

3. Departments of Surgery (Urology) and Surgical Oncology; University Health Network; Princess Margaret Cancer Centre; University of Toronto; Toronto ON Canada

4. Department of Radiation Oncology; Princess Margaret Cancer Centre; Toronto ON Canada

5. British Columbia Cancer Agency; Vancouver BC Canada

6. Microarray Centre; University Health Network; Toronto ON Canada

7. Princess Margaret Genomics Centre; University Health Network; Toronto ON Canada

8. Department of Pathology; University Health Network; Toronto ON Canada

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14372/fullpdf

Reference32 articles.

1. International trends in the incidence of testicular cancer, 1973-2002;Chia;Cancer Epidemiol Biomarkers Prev,2010

2. Evidence for increasing incidence of abnormalities of the human testis: a review;Giwercman;Environ Health Perspect,1993

3. Curing metastatic cancer: lessons from testicular germ-cell tumours;Masters;Nat Rev Cancer,2003

4. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance;Kollmannsberger;J Clin Oncol,2015

5. Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance;Chung;Cancer Med,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive characteristics of pathological subtypes in testicular germ cell tumor: Gene expression, mutation and alternative splicing;Frontiers in Immunology;2023-01-13

2. Biomarkers of disease recurrence in stage I testicular germ cell tumours;Nature Reviews Urology;2022-08-26

3. Genetics of testicular cancer: a review;Current Opinion in Urology;2022-07-18

4. Treatment options in stage I seminoma;Oncology Research;2022

5. Development and Validation of a Gene Signature for Prediction of Relapse in Stage I Testicular Germ Cell Tumors;Frontiers in Oncology;2020-07-30